In previous studies, it has also been found that myricetin causes HepG2 cell cycle arrest by inactivating the cyclin B/CDK1 complex and inhibiting CDK1 activity in HCC cells [5]. The gene discussed is CDK1; the disease is hepatocellular carcinoma.